You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

upadacitinib

Showing 26 - 44 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Elsubrutinib, Placebo for Elsubrutinib, Upadacitinib)

Completed
  • Systemic Lupus Erythematosus (SLE)
  • Mesa, Arizona
  • +159 more
Dec 19, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))

Completed
Has Results
  • Rheumatoid Arthritis
  • Upadacitinib
  • Pneumococcal 13-valent conjugate vaccine (PCV-13)
  • Huntsville, Alabama
  • +123 more
Jun 15, 2022

Atopic Dermatitis Trial in Worldwide (Upadacitinib)

Not yet recruiting
  • Atopic Dermatitis
  • Upadacitinib
  • Kogarah, New South Wales, Australia
  • +136 more
Aug 18, 2022

Ulcerative Colitis (UC) Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Ulcerative Colitis (UC)
  • Placebo
  • Upadacitinib
  • Birmingham, Alabama
  • +495 more
Jun 3, 2022

Atopic Dermatitis Trial in Worldwide (Upadacitinib, Dupilumab)

Recruiting
  • Atopic Dermatitis
  • Phoenix, Arizona
  • +297 more
Feb 1, 2023

Giant Cell Arteritis (GCA) Trial in Worldwide (Upadacitinib, Corticosteroid (CS), Placebo)

Recruiting
  • Giant Cell Arteritis (GCA)
  • Upadacitinib
  • +2 more
  • Huntsville, Alabama
  • +173 more
Aug 23, 2022

Atopic Dermatitis Trial in Worldwide (Placebo for Upadacitinib, Upadacitinib)

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Placebo for Upadacitinib
  • Upadacitinib
  • Birmingham, Alabama
  • +195 more
Mar 1, 2022

Atopic Dermatitis Trial in Worldwide (Placebo, Upadacitinib, Topical corticosteroids (TCS))

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +189 more
Mar 8, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

Active, not recruiting
Has Results
  • Rheumatoid Arthritis
  • Placebo for Adalimumab
  • +3 more
  • Birmingham, Alabama
  • +369 more
Jun 14, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo
  • Upadacitinib
  • Mesa, Arizona
  • +166 more
Mar 17, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Upadacitinib
  • Placebo
  • Huntsville, Alabama
  • +187 more
Feb 14, 2022

Psoriatic Arthritis Trial in Worldwide (Adalimumab, Upadacitinib, Placebo to Upadacitinib)

Active, not recruiting
Has Results
  • Psoriatic Arthritis
  • Huntsville, Alabama
  • +344 more
Dec 27, 2021

Atopic Dermatitis Trial in Worldwide (Placebo for Upadacitinib, Upadacitinib)

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Placebo for Upadacitinib
  • Upadacitinib
  • Phoenix, Arizona
  • +179 more
Feb 2, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo
  • Upadacitinib
  • Hemet, California
  • +62 more
Jul 28, 2021

Ulcerative Colitis (UC) Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Ulcerative Colitis (UC)
  • Placebo
  • Upadacitinib
  • Mobile, Alabama
  • +378 more
Feb 17, 2022

Atopic Dermatitis Trial in Worldwide (Upadacitinib, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Upadacitinib
  • Placebo
  • Tampa, Florida
  • +33 more
Jul 1, 2020

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Huntsville, Alabama
  • +114 more
Apr 6, 2021

Spondyloarthritis Trial in Worldwide (Upadacitinib, Placebo)

Active, not recruiting
  • Spondyloarthritis
  • Upadacitinib
  • Placebo
  • Flagstaff, Arizona
  • +211 more
Oct 19, 2021

Crohn's Disease Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib)

Completed
  • Crohn's Disease
  • Upadacitinib
  • Placebo for Upadacitinib
  • Mobile, Alabama
  • +431 more
Feb 3, 2022